
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations

